MedPath
NMPA Approval

Emedastine Difumarate Eye Drops

国药准字H20258020

February 21, 2025

国药准字HJ20181192

Drug Information

富马酸依美斯汀滴眼液

滴眼剂

0.05%(5ml:2.5mg,按C₁₇H₂₆N₄O计)

化学药品

February 21, 2025

Company Information

Applicant Company

苏州市吴中区郭巷街道尹中南路1858号

Manufacturing Company

苏州市吴中区郭巷街道尹中南路1858号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

富马酸依美斯汀滴眼液 - NMPA 批准文号 | MedPath